This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Foundation for Biomedical Research and Innovation, Kyoto Prefectural Public University Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: Satoru Yamagami: Innovator in Epithelial Cell Technology
Introduction
Satoru Yamagami is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical research, particularly in the production of epithelial cell sheets. His innovative methods have the potential to advance regenerative medicine and tissue engineering.
Latest Patents
Yamagami holds a patent for a "Method for producing cultivated epithelial cell sheet." This method involves culturing cells derived from oral mucosal epithelial cells on a substrate in a serum-free medium. The serum-free medium comprises epidermal growth factor (EGF) or keratinocyte growth factor (KGF), a B-27 supplement, and a ROCK inhibitor. This patent highlights his expertise in cell culture techniques and their applications in medical science.
Career Highlights
Throughout his career, Yamagami has worked with esteemed institutions such as the Kyoto Prefectural Public University Corporation and the Foundation for Biomedical Research and Innovation at Kobe. His work in these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in the field of cell biology.
Collaborations
Yamagami has collaborated with notable colleagues, including Takahiro Nakamura and Shigeru Kinoshita. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of biomedical research.
Conclusion
Satoru Yamagami's contributions to the field of epithelial cell technology demonstrate his commitment to advancing medical science. His innovative methods and collaborations with esteemed institutions and colleagues highlight his role as a key figure in the development of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile